← Human Trials & Peer-Reviewed Studies
The Effects of Magnesium and Zinc Co-Supplementation on Biomarkers of Inflammation and Oxidative Stress, and Gene Expression Related to Inflammation in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Trial.
Plain-language guide to PMID 29127547 (2018): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 60 subjects.
Key Facts
- PMID
- 29127547
- Journal
- Biological trace element research
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Afshar Ebrahimi F et al. (5 authors)
- DOI
- 10.1007/s12011-017-1198-5
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
This study was conducted to evaluate the effects of magnesium and zinc co-supplementation on biomarkers of inflammation and oxidative stress and gene expression related to inflammation in subjects with PCOS.
Why It Was Studied
To their knowledge, data on the effects of magnesium and zinc co-supplementation on biomarkers of inflammation and oxidative stress and gene expression related to inflammation in subjects of polycystic ovary syndrome (PCOS) are scarce.
This randomized double-blind, placebo-controlled trial was conducted among 60 subjects with PCOS diagnosed according to the Rotterdam criteria, aged 18-40 years old.
Who Took Part
According to the abstract, 60 subjects were involved.
The age groups tagged for this paper are teenagers, young adults and adults, women only.
Biomarkers of inflammation and oxidative stress were assessed at baseline and at end of treatment.
Gene expression related to inflammatory cytokines was assessed in peripheral blood mononuclear cells (PBMCs) of PCOS women with RT-PCR method.
How the Study Was Run
The design is described as randomized, double-blind and placebo-controlled.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
Blinding on both sides kept the subjects and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
What Was Measured
The subject headings attached to it are Antioxidants, Biomarkers, C-Reactive Protein, Cytokines, Dietary Supplements, Gene Expression and Inflammation.
The authors tagged it with the keywords Co-supplementation, Oxidative stress and Polycystic ovary syndrome.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 60 subjects.
The publication is from 2018 (Biological trace element research), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.